Updated:
Fåhraeus Startup and Growth
Fåhraeus Startup and Growth is a venture capital fund that invests in early-stage startups in diagnostics and pharma. It maintains a dedicated focus on life...
Overview
Fåhraeus Startup and Growth is a venture capital fund that invests in early-stage startups in diagnostics and pharma. It maintains a dedicated focus on life science and technology. The team combines operational experience with investment expertise.
General information
Firm type
Private Equity
Year founded
2021
Location
Region
Europe
Country
Sweden
City
Lund
Corporate office
Lund, Sweden
Principals
Christer Fåhraeus
Founder
Sector focus
Frequently asked questions
How does Fåhraeus Startup and Growth source deals?
The firm draws on Christer Fåhraeus's two decades of operating and investing experience in the Nordic life-science ecosystem. It relies on a network built through serial entrepreneurship and prior family-office investing rather than on a formal scout program or proprietary data platform. The fund's website invites revenue-generating companies to submit pitch decks directly, emphasizing commercial traction as a filter.
What investment stages does the fund target?
The fund targets commercial-stage, revenue-generating companies rather than pre-revenue science projects. It writes initial checks of €1 million to €6 million and looks for ventures that have already demonstrated customer traction and are ready to scale across the Nordics and Europe.
Which sectors does Fåhraeus Startup and Growth explicitly focus on?
The firm concentrates on life science — specifically diagnostics and pharmaceuticals — and selected technology companies. It operates at the intersection of those two domains, prioritizing startups where scientific innovation has already been translated into a working product with commercial demand.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: